Funding sources No external funding.
A case of xanthoma disseminatum: evaluation and monitoring by 18F-fluorodeoxyglucose positron emission tomography/computed tomography
Article first published online: 19 MAY 2014
© 2013 British Association of Dermatologists
British Journal of Dermatology
Volume 170, Issue 5, pages 1177–1181, May 2014
How to Cite
Jin, S., Chae, S.Y., Chang, S.E., Suh, C., Lee, S.W. and Ryu, J.S. (2014), A case of xanthoma disseminatum: evaluation and monitoring by 18F-fluorodeoxyglucose positron emission tomography/computed tomography. British Journal of Dermatology, 170: 1177–1181. doi: 10.1111/bjd.12789
Conflicts of interest None declared.
- Issue published online: 19 MAY 2014
- Article first published online: 19 MAY 2014
- Accepted manuscript online: 16 DEC 2013 12:20AM EST
- Manuscript Accepted: 10 DEC 2013
Xanthoma disseminatum (XD) is a rare benign histiocytic disorder with extensive mucocutaneous xanthomas that often involves other sites such as the central nervous system (CNS), respiratory tract and abdominal organs. Evaluation of the extent of disease is important because lesions in critical locations may increase morbidity and mortality. However, there are no well-established tools for the evaluation and monitoring of XD. Here, we report a case of XD in a 21-year-old male patient showing skin, mucous membrane, CNS and internal organ involvement. In this case, 18F-fluorodeoxyglucose positron emission tomography/computed tomography was useful in detecting the extent of the disease and in estimating the therapeutic response.